CH494222A - Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen - Google Patents
Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanenInfo
- Publication number
- CH494222A CH494222A CH73167A CH73167A CH494222A CH 494222 A CH494222 A CH 494222A CH 73167 A CH73167 A CH 73167A CH 73167 A CH73167 A CH 73167A CH 494222 A CH494222 A CH 494222A
- Authority
- CH
- Switzerland
- Prior art keywords
- isoflavans
- cis
- aryl
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
- C07F9/65522—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEM0068414 | 1966-02-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH494222A true CH494222A (de) | 1970-07-31 |
Family
ID=7312594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH73167A CH494222A (de) | 1966-02-16 | 1967-01-18 | Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US3535344A (de) |
| BE (1) | BE694025A (de) |
| CH (1) | CH494222A (de) |
| DE (1) | DE1543749A1 (de) |
| DK (1) | DK118611B (de) |
| ES (1) | ES336869A1 (de) |
| FR (1) | FR6192M (de) |
| GB (1) | GB1103094A (de) |
| IL (1) | IL27321A (de) |
| NL (1) | NL6702140A (de) |
| SE (1) | SE328301B (de) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4053626A (en) * | 1973-03-13 | 1977-10-11 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Cholesterol level-lowering phenoxyacetic acids |
| PT656786E (pt) * | 1992-05-19 | 2004-11-30 | Novogen Res Pty Ltd | Utilizacao de extractos do fitoestrogenio isoflavona de soja ou trevo |
| US5446061A (en) * | 1993-11-05 | 1995-08-29 | Eli Lilly And Company | Methods for lowering serum cholesterol |
| US5407955A (en) * | 1994-02-18 | 1995-04-18 | Eli Lilly And Company | Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease |
| US5446071A (en) * | 1994-11-18 | 1995-08-29 | Eli Lilly And Company | Methods for lowering serum cholesterol |
| CA2208859A1 (en) * | 1995-01-13 | 1996-07-18 | Novo Nordisk A/S | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative treatment |
| AUPO203996A0 (en) * | 1996-08-30 | 1996-09-26 | Novogen Research Pty Ltd | Therapeutic uses |
| AU4772097A (en) * | 1996-10-28 | 1998-05-22 | Novo Nordisk A/S | Novel (cis)-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| AU4699897A (en) * | 1996-10-28 | 1998-05-22 | Novo Nordisk A/S | Novel (-)-enantiomers of (cis)-3,4-chroman derivatives useful in the preve ntion or treatment of estrogen related diseases or syndromes |
| US5958967A (en) * | 1996-10-28 | 1999-09-28 | Novo Nordisk A/S | Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| IL129622A0 (en) * | 1996-10-28 | 2000-02-29 | Novo Nordisk As | Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| US5919817A (en) * | 1996-10-28 | 1999-07-06 | Novo Nordisk A/S | Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| US6316494B1 (en) | 1996-10-28 | 2001-11-13 | Novo Nordisk A/S | cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| US5994390A (en) * | 1996-10-28 | 1999-11-30 | Novo Nordisk | Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| JP2002503213A (ja) * | 1996-10-28 | 2002-01-29 | ノボ ノルディスク アクティーゼルスカブ | エストロゲン関連疾患または症候群の防止または治療に有用な新規なｃｉｓ―３，４―クロマン誘導体 |
| ZA979644B (en) * | 1996-10-28 | 1998-04-28 | Novo Nordisk As | Heterocyclic compounds, compositions and uses. |
| US6043269A (en) * | 1996-10-28 | 2000-03-28 | Novo Nordisk A/S | cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| JP2001502706A (ja) * | 1996-10-28 | 2001-02-27 | ノボ ノルディスク アクティーゼルスカブ | エストロゲン関連病あるいは症候群の予防または治療に有用な新規トランス―３，４クロマン誘導体 |
| US5985306A (en) * | 1996-10-28 | 1999-11-16 | Novo Nordisk A/S | (+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes |
| ATE229519T1 (de) * | 1996-10-28 | 2002-12-15 | Novo Nordisk As | Neue cis-3,4-chromanderivate zur vorbeugung oder behandlung von oestrogenbezogenen krankheiten oder syndromen |
| CA2270055A1 (en) * | 1996-10-28 | 1998-05-07 | Novo Nordisk A/S | Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| AU4772297A (en) * | 1996-10-28 | 1998-05-22 | Novo Nordisk A/S | Novel (cis)-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| US6146668A (en) | 1997-04-28 | 2000-11-14 | Novogen, Inc. | Preparation of isoflavones from legumes |
| CA2287965C (en) * | 1997-05-01 | 2009-10-20 | Graham Edmund Kelly | Treatment or prevention of menopausal symptoms and osteoporosis |
| AUPP112497A0 (en) * | 1997-12-24 | 1998-01-22 | Novogen Research Pty Ltd | Compositions and method for protecting skin from UV induced immunosupression and skin damage |
| AUPP260798A0 (en) | 1998-03-26 | 1998-04-23 | Novogen Research Pty Ltd | Treatment of medical related conditions with isoflavone containing extracts of clover |
| KR20000001793A (ko) | 1998-06-13 | 2000-01-15 | 이경하 | 신규한 벤조피란 또는 티오벤조피란 유도체 |
| AUPP868599A0 (en) * | 1999-02-15 | 1999-03-11 | Novogen Research Pty Ltd | Production of isoflavone derivatives |
| AUPQ266199A0 (en) * | 1999-09-06 | 1999-09-30 | Novogen Research Pty Ltd | Compositions and therapeutic methods involving isoflavones and analogues thereof |
| US20090233999A1 (en) * | 1999-09-06 | 2009-09-17 | Novogen Research Pty Ltd | Compositions and therapeutic methods involving isoflavones and analogues thereof |
| AUPQ520300A0 (en) * | 2000-01-21 | 2000-02-17 | Novogen Research Pty Ltd | Food product and process |
| AU2001256164A1 (en) | 2000-03-01 | 2001-09-12 | Akzo Nobel N.V. | Chroman derivatives as estrogenic compounds |
| AUPR363301A0 (en) * | 2001-03-08 | 2001-04-05 | Novogen Research Pty Ltd | Dimeric isoflavones |
| US20050119301A1 (en) * | 2001-03-16 | 2005-06-02 | Alan Husband | Treatment of restenosis |
| AU2004290613B2 (en) * | 2003-11-18 | 2010-03-25 | Novogen Research Pty Ltd | Isoflavonoid prodrugs, compositions thereof and therapeutic methods involving same |
| CN1902213B (zh) * | 2003-11-18 | 2010-06-23 | 诺沃根研究股份有限公司 | 异黄酮类前药、其组合物和涉及它们的治疗方法 |
| US7601855B2 (en) | 2004-09-21 | 2009-10-13 | Novogen Research Pty Ltd | Substituted chroman derivatives, medicaments and use in therapy |
| US8080675B2 (en) | 2004-09-21 | 2011-12-20 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
| EP2635121B1 (de) | 2010-11-01 | 2020-01-08 | MEI Pharma, Inc. | Isoflavonoidverbindungen und verfahren zur behandlung von krebs |
| HUE054998T2 (hu) | 2015-02-02 | 2021-10-28 | Mei Pharma Inc | Kombinációs terápiák emlõrák kezelésében való alkalmazásra |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3340276A (en) * | 1964-04-01 | 1967-09-05 | Ciba Geigy Corp | 3, 4-diphenyl-chromans |
| CH471113A (de) * | 1965-01-29 | 1969-04-15 | Merck Ag E | Verfahren zur Herstellung von wasserlöslichen Flavanoidderivaten |
| US3436393A (en) * | 1965-12-27 | 1969-04-01 | Parke Davis & Co | 4'-methoxy-2,2,4-trialkyl-delta**3-isoflavan compounds |
-
1966
- 1966-02-16 DE DE19661543749 patent/DE1543749A1/de active Pending
-
1967
- 1967-01-18 CH CH73167A patent/CH494222A/de not_active IP Right Cessation
- 1967-01-20 GB GB3175/67A patent/GB1103094A/en not_active Expired
- 1967-01-25 IL IL27321A patent/IL27321A/en unknown
- 1967-02-13 NL NL6702140A patent/NL6702140A/xx unknown
- 1967-02-13 FR FR94664A patent/FR6192M/fr not_active Expired
- 1967-02-13 US US615391A patent/US3535344A/en not_active Expired - Lifetime
- 1967-02-13 BE BE694025D patent/BE694025A/xx unknown
- 1967-02-14 DK DK80167AA patent/DK118611B/da unknown
- 1967-02-15 SE SE02111/67A patent/SE328301B/xx unknown
- 1967-02-15 ES ES336869A patent/ES336869A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| US3535344A (en) | 1970-10-20 |
| DE1543749A1 (de) | 1969-12-11 |
| IL27321A (en) | 1970-09-17 |
| GB1103094A (en) | 1968-02-14 |
| ES336869A1 (es) | 1968-05-01 |
| NL6702140A (de) | 1967-08-17 |
| BE694025A (de) | 1967-08-14 |
| SE328301B (de) | 1970-09-14 |
| DK118611B (da) | 1970-09-14 |
| FR6192M (de) | 1968-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH494222A (de) | Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen | |
| CH490323A (de) | Verfahren zur Herstellung von 3,4-Dihydroxyphenylalkanolaminen | |
| CH487894A (de) | Verfahren zur Herstellung von 1,2,3,4-Tetrahydro-9-aminoacridinen | |
| AT271479B (de) | Verfahren zur Herstellung von 2,4-Diamino-5-benzylpyrimidinen | |
| CH481924A (de) | Verfahren zur Herstellung von 6-Aminophenyl- und 6-Acylaminophenyl-4,5-dihydropyridazonen (3) | |
| CH449011A (de) | Verfahren zur Herstellung von 2,3-Pyridindiol | |
| CH485694A (de) | Verfahren zur Herstellung von 4,7a-Dimethyl-4-androstenen | |
| CH487096A (de) | Verfahren zur Herstellung von 4,4'-Dohydroxy-stilbenen | |
| CH481935A (de) | Verfahren zur Herstellung von N-Acyl-3,4-dihydrooxazinen-(1,3) | |
| CH506548A (de) | Verfahren zur Herstellung von 2-aminsubstituiertem 4,5-Diphenyl-Oxazol | |
| AT275060B (de) | Verfahren zur Herstellung von 1β-Hydroxy-5-oxo-4-(2'-carboxy-äthyl)-7aβ-R-3aα-4β,5,6,7,7a-hexahydroindanen | |
| AT277240B (de) | Verfahren zur Herstellung von 6-Styryl-5,6-dihydro-α-pyronen | |
| AT259771B (de) | Verfahren zur Herstellung von 6,7-Benzomorphanen | |
| CH471072A (de) | Verfahren zur Herstellung von 3,4-Dihydroxy-phenyl-alkanolaminen | |
| CH490342A (de) | Verfahren zur Herstellung von 2,6-Dicyan-4-nitranilin | |
| CH493545A (de) | Verfahren zur Herstellung von Derivaten von 1,2,3,4-Tetrahydro-5H-pyrido-(4,3b)-indolen | |
| CH475264A (de) | Verfahren zur Herstellung von 2-Arylamino-4,6-dichlor-s-triazinen | |
| CH483434A (de) | Verfahren zur Herstellung von 1,2-Dihydrobenzodiazepinen | |
| AT266800B (de) | Verfahren zur Herstellung von 2-Thiapropandiol-(1,3) | |
| AT292662B (de) | Verfahren zur Herstellung von 1,1'-Peroxydicyclohexylamin | |
| CH487170A (de) | Verfahren zur Herstellung von 1,4-Diazacycloheptanen | |
| CH487851A (de) | Verfahren zur Herstellung von 2,2,2-Trichloräthylidenanilinen | |
| CH478129A (de) | Verfahren zur Herstellung von 1,4-Diaza-4-cycloheptenen | |
| CH476693A (de) | Verfahren zur Herstellung von 1,2,3-Trichlor-2-cyanpropan | |
| CH523275A (de) | Verfahren zur Herstellung von 3,1-Benzothiazin-Derivaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |